nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—DRD3—hypertension	0.12	0.449	CbGaD
Mesoridazine—DRD2—hypertension	0.0831	0.311	CbGaD
Mesoridazine—HTR2A—hypertension	0.0642	0.24	CbGaD
Mesoridazine—Encainide—Diltiazem—hypertension	0.0629	0.22	CrCrCtD
Mesoridazine—KCNH2—Terazosin—hypertension	0.0276	0.0822	CbGbCtD
Mesoridazine—Cyamemazine—Diltiazem—hypertension	0.0261	0.0915	CrCrCtD
Mesoridazine—HTR1A—Nebivolol—hypertension	0.0255	0.076	CbGbCtD
Mesoridazine—Triflupromazine—Diltiazem—hypertension	0.0248	0.0869	CrCrCtD
Mesoridazine—Methotrimeprazine—Diltiazem—hypertension	0.0248	0.0869	CrCrCtD
Mesoridazine—Aceprometazine—Diltiazem—hypertension	0.0242	0.0848	CrCrCtD
Mesoridazine—Acepromazine—Diltiazem—hypertension	0.0236	0.0828	CrCrCtD
Mesoridazine—Propiomazine—Diltiazem—hypertension	0.0236	0.0828	CrCrCtD
Mesoridazine—KCNH2—Doxazosin—hypertension	0.023	0.0686	CbGbCtD
Mesoridazine—HTR1A—Pindolol—hypertension	0.0217	0.0647	CbGbCtD
Mesoridazine—Chlorpromazine—Diltiazem—hypertension	0.02	0.0699	CrCrCtD
Mesoridazine—KCNH2—Bepridil—hypertension	0.0198	0.0591	CbGbCtD
Mesoridazine—Promethazine—Diltiazem—hypertension	0.0196	0.0686	CrCrCtD
Mesoridazine—Alimemazine—Diltiazem—hypertension	0.0192	0.0673	CrCrCtD
Mesoridazine—KCNH2—Prazosin—hypertension	0.0189	0.0563	CbGbCtD
Mesoridazine—HTR1A—Penbutolol—hypertension	0.0177	0.0527	CbGbCtD
Mesoridazine—Promazine—Diltiazem—hypertension	0.0166	0.058	CrCrCtD
Mesoridazine—KCNH2—Carvedilol—hypertension	0.0163	0.0486	CbGbCtD
Mesoridazine—DRD2—Fenoldopam—hypertension	0.0162	0.0484	CbGbCtD
Mesoridazine—HTR1A—Prazosin—hypertension	0.014	0.0417	CbGbCtD
Mesoridazine—HTR1A—Propranolol—hypertension	0.0111	0.0331	CbGbCtD
Mesoridazine—CHRM2—Nicardipine—hypertension	0.0105	0.0314	CbGbCtD
Mesoridazine—KCNH2—Verapamil—hypertension	0.0103	0.0307	CbGbCtD
Mesoridazine—CYP2D6—Labetalol—hypertension	0.00811	0.0242	CbGbCtD
Mesoridazine—CYP2D6—Nebivolol—hypertension	0.00811	0.0242	CbGbCtD
Mesoridazine—CYP2D6—Acebutolol—hypertension	0.00742	0.0221	CbGbCtD
Mesoridazine—CYP2D6—Metoprolol—hypertension	0.00689	0.0206	CbGbCtD
Mesoridazine—CYP2D6—Pindolol—hypertension	0.00689	0.0206	CbGbCtD
Mesoridazine—CYP2D6—Betaxolol—hypertension	0.00614	0.0183	CbGbCtD
Mesoridazine—CYP2D6—Doxazosin—hypertension	0.00541	0.0161	CbGbCtD
Mesoridazine—CYP2D6—Diltiazem—hypertension	0.00522	0.0156	CbGbCtD
Mesoridazine—CYP2D6—Bepridil—hypertension	0.00466	0.0139	CbGbCtD
Mesoridazine—CYP2D6—Irbesartan—hypertension	0.00426	0.0127	CbGbCtD
Mesoridazine—CYP2D6—Amlodipine—hypertension	0.00418	0.0125	CbGbCtD
Mesoridazine—CYP2D6—Felodipine—hypertension	0.00403	0.012	CbGbCtD
Mesoridazine—CYP2D6—Timolol—hypertension	0.00396	0.0118	CbGbCtD
Mesoridazine—CYP2D6—Nifedipine—hypertension	0.0039	0.0116	CbGbCtD
Mesoridazine—CYP2D6—Nicardipine—hypertension	0.00383	0.0114	CbGbCtD
Mesoridazine—CYP2D6—Carvedilol—hypertension	0.00383	0.0114	CbGbCtD
Mesoridazine—CYP2D6—Propranolol—hypertension	0.00353	0.0105	CbGbCtD
Mesoridazine—CYP2D6—Captopril—hypertension	0.00349	0.0104	CbGbCtD
Mesoridazine—CYP2D6—Clonidine—hypertension	0.00337	0.01	CbGbCtD
Mesoridazine—CYP2D6—Atorvastatin—hypertension	0.003	0.00895	CbGbCtD
Mesoridazine—CYP2D6—Verapamil—hypertension	0.00242	0.00723	CbGbCtD
Mesoridazine—HTR2A—arteriole—hypertension	0.00193	0.0884	CbGeAlD
Mesoridazine—HTR2A—locus ceruleus—hypertension	0.00156	0.0712	CbGeAlD
Mesoridazine—HTR2A—pulmonary artery—hypertension	0.00127	0.0579	CbGeAlD
Mesoridazine—HTR2A—sympathetic nervous system—hypertension	0.00123	0.0563	CbGeAlD
Mesoridazine—HTR2A—vagus nerve—hypertension	0.00119	0.0545	CbGeAlD
Mesoridazine—HTR2A—vein—hypertension	0.00115	0.0527	CbGeAlD
Mesoridazine—HTR2A—autonomic nervous system—hypertension	0.000827	0.0379	CbGeAlD
Mesoridazine—HTR2A—hindlimb—hypertension	0.000765	0.035	CbGeAlD
Mesoridazine—HTR2A—urine—hypertension	0.000674	0.0309	CbGeAlD
Mesoridazine—CYP2D6—urine—hypertension	0.000614	0.0281	CbGeAlD
Mesoridazine—HTR2A—artery—hypertension	0.000469	0.0215	CbGeAlD
Mesoridazine—HTR2C—brainstem—hypertension	0.000398	0.0182	CbGeAlD
Mesoridazine—HTR2A—endothelium—hypertension	0.000396	0.0181	CbGeAlD
Mesoridazine—KCNH2—cardiac ventricle—hypertension	0.000393	0.018	CbGeAlD
Mesoridazine—KCNH2—myocardium—hypertension	0.00037	0.0169	CbGeAlD
Mesoridazine—HTR2A—blood vessel—hypertension	0.000365	0.0167	CbGeAlD
Mesoridazine—DRD3—central nervous system—hypertension	0.000361	0.0165	CbGeAlD
Mesoridazine—CHRM2—heart—hypertension	0.000357	0.0164	CbGeAlD
Mesoridazine—HTR6—central nervous system—hypertension	0.000348	0.0159	CbGeAlD
Mesoridazine—CHRM2—cardiovascular system—hypertension	0.000337	0.0154	CbGeAlD
Mesoridazine—HTR1A—brainstem—hypertension	0.000335	0.0153	CbGeAlD
Mesoridazine—DRD2—brainstem—hypertension	0.000303	0.0139	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—hypertension	0.000278	0.0127	CbGeAlD
Mesoridazine—HTR1A—cardiovascular system—hypertension	0.000273	0.0125	CbGeAlD
Mesoridazine—KCNH2—heart—hypertension	0.000258	0.0118	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—hypertension	0.000243	0.0111	CbGeAlD
Mesoridazine—CHRM2—endocrine gland—hypertension	0.000231	0.0106	CbGeAlD
Mesoridazine—KCNH2—cardiac atrium—hypertension	0.000221	0.0101	CbGeAlD
Mesoridazine—HTR1A—adrenal gland—hypertension	0.000216	0.0099	CbGeAlD
Mesoridazine—CHRM2—central nervous system—hypertension	0.000208	0.00954	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—hypertension	0.000208	0.00952	CbGeAlD
Mesoridazine—HRH1—smooth muscle tissue—hypertension	0.000205	0.00939	CbGeAlD
Mesoridazine—HRH1—decidua—hypertension	0.000201	0.00921	CbGeAlD
Mesoridazine—HTR2C—central nervous system—hypertension	0.000201	0.00919	CbGeAlD
Mesoridazine—HTR2A—brainstem—hypertension	0.0002	0.00914	CbGeAlD
Mesoridazine—KCNH2—adrenal gland—hypertension	0.000193	0.00882	CbGeAlD
Mesoridazine—HTR1A—endocrine gland—hypertension	0.000188	0.00859	CbGeAlD
Mesoridazine—CYP2D6—brainstem—hypertension	0.000182	0.00833	CbGeAlD
Mesoridazine—HTR2A—heart—hypertension	0.000173	0.00791	CbGeAlD
Mesoridazine—HTR2A—smooth muscle tissue—hypertension	0.000171	0.00784	CbGeAlD
Mesoridazine—DRD2—endocrine gland—hypertension	0.000169	0.00776	CbGeAlD
Mesoridazine—HTR1A—central nervous system—hypertension	0.000169	0.00774	CbGeAlD
Mesoridazine—KCNH2—endocrine gland—hypertension	0.000167	0.00764	CbGeAlD
Mesoridazine—HTR2A—cardiovascular system—hypertension	0.000163	0.00746	CbGeAlD
Mesoridazine—HTR2A—kidney—hypertension	0.000159	0.0073	CbGeAlD
Mesoridazine—HRH1—adrenal gland—hypertension	0.000154	0.00707	CbGeAlD
Mesoridazine—DRD2—central nervous system—hypertension	0.000153	0.00699	CbGeAlD
Mesoridazine—KCNH2—central nervous system—hypertension	0.00015	0.00689	CbGeAlD
Mesoridazine—CYP2D6—kidney—hypertension	0.000145	0.00665	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—hypertension	0.000139	0.00637	CbGeAlD
Mesoridazine—HRH1—endocrine gland—hypertension	0.000134	0.00613	CbGeAlD
Mesoridazine—HTR2A—adrenal gland—hypertension	0.000129	0.0059	CbGeAlD
Mesoridazine—Fluphenazine—CALM2—hypertension	0.000128	0.0388	CrCbGaD
Mesoridazine—HRH1—central nervous system—hypertension	0.000121	0.00552	CbGeAlD
Mesoridazine—Eletriptan—HTR2B—hypertension	0.00012	0.0366	CrCbGaD
Mesoridazine—HTR2A—endocrine gland—hypertension	0.000112	0.00512	CbGeAlD
Mesoridazine—Promethazine—CALM2—hypertension	0.000103	0.0315	CrCbGaD
Mesoridazine—Trifluoperazine—CALM2—hypertension	0.000102	0.031	CrCbGaD
Mesoridazine—CYP2D6—endocrine gland—hypertension	0.000102	0.00466	CbGeAlD
Mesoridazine—Perphenazine—CALM2—hypertension	0.000101	0.0307	CrCbGaD
Mesoridazine—HTR2A—central nervous system—hypertension	0.000101	0.00461	CbGeAlD
Mesoridazine—CYP2D6—central nervous system—hypertension	9.18e-05	0.0042	CbGeAlD
Mesoridazine—Triflupromazine—HTR2B—hypertension	9.11e-05	0.0277	CrCbGaD
Mesoridazine—Fluphenazine—CALM1—hypertension	8.22e-05	0.025	CrCbGaD
Mesoridazine—Chlorpromazine—CALM2—hypertension	8e-05	0.0244	CrCbGaD
Mesoridazine—Eletriptan—HTR7—hypertension	7.44e-05	0.0227	CrCbGaD
Mesoridazine—Eletriptan—HTR1B—hypertension	7.21e-05	0.0219	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA2B—hypertension	6.99e-05	0.0213	CrCbGaD
Mesoridazine—Propericiazine—ADRA2A—hypertension	6.97e-05	0.0212	CrCbGaD
Mesoridazine—Promethazine—CALM1—hypertension	6.66e-05	0.0203	CrCbGaD
Mesoridazine—Trifluoperazine—CALM1—hypertension	6.57e-05	0.02	CrCbGaD
Mesoridazine—Perphenazine—CALM1—hypertension	6.5e-05	0.0198	CrCbGaD
Mesoridazine—Trifluoperazine—XDH—hypertension	6.42e-05	0.0195	CrCbGaD
Mesoridazine—Acepromazine—ADRA1A—hypertension	6.32e-05	0.0192	CrCbGaD
Mesoridazine—Thioproperazine—ADRA1A—hypertension	6.18e-05	0.0188	CrCbGaD
Mesoridazine—Acetophenazine—DRD2—hypertension	5.98e-05	0.0182	CrCbGaD
Mesoridazine—Chlorpromazine—CALM1—hypertension	5.16e-05	0.0157	CrCbGaD
Mesoridazine—Propiomazine—ADRA1A—hypertension	5.06e-05	0.0154	CrCbGaD
Mesoridazine—Eletriptan—PTGS1—hypertension	5.03e-05	0.0153	CrCbGaD
Mesoridazine—Perphenazine—CYP2C18—hypertension	4.75e-05	0.0144	CrCbGaD
Mesoridazine—Thioridazine—ADRA1A—hypertension	4.53e-05	0.0138	CrCbGaD
Mesoridazine—Prochlorperazine—DRD3—hypertension	4.51e-05	0.0137	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2B—hypertension	4.4e-05	0.0134	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA1A—hypertension	4.32e-05	0.0132	CrCbGaD
Mesoridazine—Thiothixene—ADRA2A—hypertension	4.31e-05	0.0131	CrCbGaD
Mesoridazine—Promethazine—ADRA1A—hypertension	4.26e-05	0.013	CrCbGaD
Mesoridazine—Trifluoperazine—ADRA1A—hypertension	4.2e-05	0.0128	CrCbGaD
Mesoridazine—Cyamemazine—HTR2A—hypertension	4.09e-05	0.0124	CrCbGaD
Mesoridazine—Fluphenazine—DRD3—hypertension	4.08e-05	0.0124	CrCbGaD
Mesoridazine—Promazine—ADRA1A—hypertension	3.75e-05	0.0114	CrCbGaD
Mesoridazine—Thioridazine—HTR7—hypertension	3.74e-05	0.0114	CrCbGaD
Mesoridazine—Fluphenazine—ADRA2A—hypertension	3.72e-05	0.0113	CrCbGaD
Mesoridazine—Triflupromazine—DRD2—hypertension	3.67e-05	0.0112	CrCbGaD
Mesoridazine—Perphenazine—HTR7—hypertension	3.43e-05	0.0104	CrCbGaD
Mesoridazine—Acepromazine—DRD2—hypertension	3.4e-05	0.0103	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD3—hypertension	3.36e-05	0.0102	CrCbGaD
Mesoridazine—Thioproperazine—DRD2—hypertension	3.32e-05	0.0101	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA1A—hypertension	3.3e-05	0.01	CrCbGaD
Mesoridazine—Pipotiazine—DRD2—hypertension	3.27e-05	0.00994	CrCbGaD
Mesoridazine—Thiothixene—DRD2—hypertension	3.27e-05	0.00994	CrCbGaD
Mesoridazine—Thioridazine—ADRA2A—hypertension	3.21e-05	0.00976	CrCbGaD
Mesoridazine—Prochlorperazine—DRD2—hypertension	3.12e-05	0.0095	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA2A—hypertension	3.06e-05	0.00931	CrCbGaD
Mesoridazine—Perphenazine—ADRA2A—hypertension	2.94e-05	0.00895	CrCbGaD
Mesoridazine—Fluphenazine—DRD2—hypertension	2.82e-05	0.00859	CrCbGaD
Mesoridazine—Chlorpromazine—HTR7—hypertension	2.72e-05	0.00828	CrCbGaD
Mesoridazine—Propiomazine—DRD2—hypertension	2.72e-05	0.00826	CrCbGaD
Mesoridazine—Promazine—ADRA2A—hypertension	2.65e-05	0.00807	CrCbGaD
Mesoridazine—Acepromazine—HTR2A—hypertension	2.62e-05	0.00799	CrCbGaD
Mesoridazine—Thioproperazine—HTR2A—hypertension	2.57e-05	0.00781	CrCbGaD
Mesoridazine—Chlorpromazine—DRD3—hypertension	2.56e-05	0.00779	CrCbGaD
Mesoridazine—Thiothixene—HTR2A—hypertension	2.52e-05	0.00768	CrCbGaD
Mesoridazine—Pipotiazine—HTR2A—hypertension	2.52e-05	0.00768	CrCbGaD
Mesoridazine—Thioridazine—DRD2—hypertension	2.43e-05	0.0074	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA2A—hypertension	2.33e-05	0.0071	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD2—hypertension	2.32e-05	0.00707	CrCbGaD
Mesoridazine—Promethazine—DRD2—hypertension	2.29e-05	0.00696	CrCbGaD
Mesoridazine—Trifluoperazine—DRD2—hypertension	2.26e-05	0.00687	CrCbGaD
Mesoridazine—Perphenazine—DRD2—hypertension	2.23e-05	0.00679	CrCbGaD
Mesoridazine—Fluphenazine—HTR2A—hypertension	2.18e-05	0.00664	CrCbGaD
Mesoridazine—Propiomazine—HTR2A—hypertension	2.1e-05	0.00639	CrCbGaD
Mesoridazine—Promazine—DRD2—hypertension	2.01e-05	0.00612	CrCbGaD
Mesoridazine—Thioridazine—HTR2A—hypertension	1.88e-05	0.00572	CrCbGaD
Mesoridazine—Acepromazine—ALB—hypertension	1.8e-05	0.00547	CrCbGaD
Mesoridazine—Methotrimeprazine—HTR2A—hypertension	1.79e-05	0.00546	CrCbGaD
Mesoridazine—Chlorpromazine—DRD2—hypertension	1.77e-05	0.00539	CrCbGaD
Mesoridazine—Promethazine—HTR2A—hypertension	1.77e-05	0.00538	CrCbGaD
Mesoridazine—Thioproperazine—ALB—hypertension	1.76e-05	0.00534	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—hypertension	1.74e-05	0.00531	CrCbGaD
Mesoridazine—Pipotiazine—ALB—hypertension	1.73e-05	0.00526	CrCbGaD
Mesoridazine—Thiothixene—ALB—hypertension	1.73e-05	0.00526	CrCbGaD
Mesoridazine—Perphenazine—HTR2A—hypertension	1.72e-05	0.00525	CrCbGaD
Mesoridazine—Promazine—HTR2A—hypertension	1.55e-05	0.00473	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2A—hypertension	1.37e-05	0.00416	CrCbGaD
Mesoridazine—Chlorpromazine—ALB—hypertension	9.36e-06	0.00285	CrCbGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT2—hypertension	1.51e-06	1.74e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—hypertension	1.5e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1—hypertension	1.5e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT2—hypertension	1.5e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—hypertension	1.49e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—F2—hypertension	1.49e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FN1—hypertension	1.49e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PRKCB—hypertension	1.49e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—COMT—hypertension	1.49e-06	1.72e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FN1—hypertension	1.49e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PRKCB—hypertension	1.49e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—F2—hypertension	1.49e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—hypertension	1.48e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH1—hypertension	1.48e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RELA—hypertension	1.48e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CDKN1A—hypertension	1.48e-06	1.71e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PTEN—hypertension	1.48e-06	1.7e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GNB3—hypertension	1.47e-06	1.69e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARGC1A—hypertension	1.47e-06	1.69e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—F2—hypertension	1.46e-06	1.69e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PRKCB—hypertension	1.46e-06	1.69e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FN1—hypertension	1.46e-06	1.69e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMOX1—hypertension	1.46e-06	1.68e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH1—hypertension	1.46e-06	1.68e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH1—hypertension	1.45e-06	1.68e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MTOR—hypertension	1.45e-06	1.67e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MAPK8—hypertension	1.44e-06	1.66e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAT—hypertension	1.44e-06	1.66e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—hypertension	1.44e-06	1.66e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SERPINE1—hypertension	1.43e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH1—hypertension	1.43e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GNAS—hypertension	1.43e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SERPINE1—hypertension	1.43e-06	1.65e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EP300—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOB—hypertension	1.4e-06	1.61e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL8—hypertension	1.39e-06	1.61e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGF2—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RHOA—hypertension	1.38e-06	1.6e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGF2—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RHOA—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INS—hypertension	1.37e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3R1—hypertension	1.37e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOS3—hypertension	1.37e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SRC—hypertension	1.37e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3R1—hypertension	1.36e-06	1.57e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOS3—hypertension	1.36e-06	1.57e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTM1—hypertension	1.36e-06	1.57e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—hypertension	1.36e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—hypertension	1.35e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INS—hypertension	1.35e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL2—hypertension	1.35e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—hypertension	1.35e-06	1.55e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INS—hypertension	1.35e-06	1.55e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—LPL—hypertension	1.34e-06	1.54e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—hypertension	1.33e-06	1.54e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—hypertension	1.33e-06	1.54e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL2—hypertension	1.33e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1—hypertension	1.33e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—hypertension	1.32e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT2—hypertension	1.32e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INS—hypertension	1.32e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL2—hypertension	1.32e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—hypertension	1.32e-06	1.52e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ADCY5—hypertension	1.31e-06	1.51e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT2—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL2—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GPX1—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT2—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—hypertension	1.3e-06	1.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—hypertension	1.3e-06	1.49e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PRKCA—hypertension	1.29e-06	1.49e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP1A1—hypertension	1.29e-06	1.49e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RELA—hypertension	1.29e-06	1.49e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RELA—hypertension	1.28e-06	1.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1—hypertension	1.28e-06	1.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT2—hypertension	1.28e-06	1.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—hypertension	1.27e-06	1.47e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CD36—hypertension	1.27e-06	1.46e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MTOR—hypertension	1.26e-06	1.46e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SERPINE1—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MTOR—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CDKN1A—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PTEN—hypertension	1.25e-06	1.45e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SERPINE1—hypertension	1.24e-06	1.43e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SERPINE1—hypertension	1.24e-06	1.43e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MYC—hypertension	1.23e-06	1.41e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MAPK8—hypertension	1.23e-06	1.41e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFB1—hypertension	1.22e-06	1.41e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—hypertension	1.22e-06	1.41e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGF2—hypertension	1.22e-06	1.41e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SERPINE1—hypertension	1.22e-06	1.4e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RHOA—hypertension	1.21e-06	1.4e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL8—hypertension	1.21e-06	1.4e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL8—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—hypertension	1.2e-06	1.39e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3R1—hypertension	1.2e-06	1.39e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOS3—hypertension	1.2e-06	1.39e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGF2—hypertension	1.2e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—hypertension	1.2e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGF2—hypertension	1.2e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RHOA—hypertension	1.19e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EP300—hypertension	1.19e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RHOA—hypertension	1.19e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3R1—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOS3—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOS3—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3R1—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARA—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF2—hypertension	1.18e-06	1.36e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RHOA—hypertension	1.17e-06	1.35e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—hypertension	1.17e-06	1.35e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—hypertension	1.17e-06	1.35e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SRC—hypertension	1.16e-06	1.34e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3R1—hypertension	1.16e-06	1.34e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOS3—hypertension	1.16e-06	1.34e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—hypertension	1.15e-06	1.33e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—hypertension	1.15e-06	1.32e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AGT—hypertension	1.14e-06	1.32e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—hypertension	1.13e-06	1.31e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RELA—hypertension	1.13e-06	1.3e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CALM1—hypertension	1.12e-06	1.3e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RELA—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RELA—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MTOR—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAV1—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOA1—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—hypertension	1.1e-06	1.27e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CDKN1A—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RELA—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PTEN—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MTOR—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MTOR—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CDKN1A—hypertension	1.09e-06	1.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PTEN—hypertension	1.09e-06	1.25e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MTOR—hypertension	1.07e-06	1.24e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MAPK8—hypertension	1.07e-06	1.23e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL8—hypertension	1.07e-06	1.23e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—hypertension	1.07e-06	1.23e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MAPK8—hypertension	1.06e-06	1.23e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—hypertension	1.06e-06	1.22e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL8—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL8—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EP300—hypertension	1.04e-06	1.2e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MYC—hypertension	1.04e-06	1.2e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFB1—hypertension	1.04e-06	1.2e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EP300—hypertension	1.04e-06	1.19e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL8—hypertension	1.03e-06	1.19e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—hypertension	1.03e-06	1.19e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—hypertension	1.02e-06	1.17e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—hypertension	1.01e-06	1.17e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—hypertension	1.01e-06	1.17e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SRC—hypertension	1.01e-06	1.17e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—hypertension	1.01e-06	1.17e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SRC—hypertension	1.01e-06	1.16e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—hypertension	1.01e-06	1.16e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—hypertension	9.98e-07	1.15e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—hypertension	9.95e-07	1.15e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—hypertension	9.95e-07	1.15e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—hypertension	9.86e-07	1.14e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—hypertension	9.81e-07	1.13e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—hypertension	9.79e-07	1.13e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—hypertension	9.75e-07	1.12e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—hypertension	9.64e-07	1.11e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—hypertension	9.61e-07	1.11e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CDKN1A—hypertension	9.61e-07	1.11e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTEN—hypertension	9.59e-07	1.11e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—INS—hypertension	9.56e-07	1.1e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—hypertension	9.49e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—hypertension	9.47e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CDKN1A—hypertension	9.45e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CDKN1A—hypertension	9.43e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTEN—hypertension	9.43e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTEN—hypertension	9.41e-07	1.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MAPK8—hypertension	9.38e-07	1.08e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—hypertension	9.35e-07	1.08e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—hypertension	9.32e-07	1.07e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CDKN1A—hypertension	9.28e-07	1.07e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTEN—hypertension	9.26e-07	1.07e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MAPK8—hypertension	9.23e-07	1.06e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—hypertension	9.21e-07	1.06e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MAPK8—hypertension	9.21e-07	1.06e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—hypertension	9.2e-07	1.06e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—hypertension	9.18e-07	1.06e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EP300—hypertension	9.14e-07	1.05e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MYC—hypertension	9.07e-07	1.05e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAPK8—hypertension	9.06e-07	1.05e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFB1—hypertension	9.05e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—hypertension	9.04e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MYC—hypertension	9.03e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFB1—hypertension	9.01e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EP300—hypertension	9e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EP300—hypertension	8.98e-07	1.04e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SRC—hypertension	8.89e-07	1.03e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—hypertension	8.88e-07	1.02e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EP300—hypertension	8.83e-07	1.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—hypertension	8.83e-07	1.02e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—hypertension	8.77e-07	1.01e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SRC—hypertension	8.75e-07	1.01e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SRC—hypertension	8.73e-07	1.01e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—hypertension	8.66e-07	9.99e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SRC—hypertension	8.59e-07	9.91e-06	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—hypertension	8.55e-07	9.86e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—hypertension	8.52e-07	9.83e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—hypertension	8.5e-07	9.81e-06	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—hypertension	8.5e-07	9.81e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NOS3—hypertension	8.38e-07	9.67e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3R1—hypertension	8.38e-07	9.67e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—hypertension	8.37e-07	9.65e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MYC—hypertension	7.97e-07	9.19e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFB1—hypertension	7.95e-07	9.17e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MYC—hypertension	7.84e-07	9.04e-06	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—hypertension	7.83e-07	9.03e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MYC—hypertension	7.82e-07	9.02e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFB1—hypertension	7.82e-07	9.02e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFB1—hypertension	7.8e-07	9e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—hypertension	7.79e-07	8.99e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MYC—hypertension	7.7e-07	8.88e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFB1—hypertension	7.68e-07	8.86e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—hypertension	7.67e-07	8.85e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—hypertension	7.67e-07	8.84e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—hypertension	7.65e-07	8.82e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—hypertension	7.53e-07	8.68e-06	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—hypertension	7.45e-07	8.6e-06	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—hypertension	7.41e-07	8.55e-06	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—hypertension	7.22e-07	8.33e-06	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—hypertension	6.82e-07	7.87e-06	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—hypertension	6.79e-07	7.83e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTEN—hypertension	6.69e-07	7.71e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—hypertension	6.54e-07	7.55e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—hypertension	6.44e-07	7.43e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—hypertension	6.42e-07	7.41e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—EP300—hypertension	6.38e-07	7.36e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—hypertension	6.32e-07	7.29e-06	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—hypertension	6.29e-07	7.26e-06	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—hypertension	6.26e-07	7.22e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—hypertension	5.99e-07	6.91e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—hypertension	5.89e-07	6.8e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—hypertension	5.88e-07	6.78e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—hypertension	5.79e-07	6.67e-06	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—hypertension	5.52e-07	6.37e-06	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—hypertension	5.44e-07	6.27e-06	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—hypertension	5.42e-07	6.26e-06	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—hypertension	5.34e-07	6.16e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—hypertension	3.85e-07	4.45e-06	CbGpPWpGaD
